US Stock MarketDetailed Quotes
MGRM Monogram Orthopaedics
- 2.720
- -0.130-4.56%
Close Dec 18 16:00 ET
93.33MMarket Cap-5.93P/E (TTM)
2.953High2.720Low143.70KVolume2.953Open2.850Pre Close408.08KTurnover0.58%Turnover RatioLossP/E (Static)34.31MShares4.90052wk High5.36P/B67.03MFloat Cap1.53052wk Low--Dividend TTM24.64MShs Float48.990Historical High--Div YieldTTM8.16%Amplitude1.530Historical Low2.839Avg Price1Lot Size
Monogram Orthopaedics Stock Forum
Sign in to post a comment
Note: This seems to be a long list. The rationale is that I al focused on at least 20% gains and not just after bangers. My trading style is to compound those 10-15-20-30% earnings and roll all profit rather than waiting for runners everyday. If runners appear, then I’ll grab it as well. Each has his own style earning.
$Damon Inc (DMN.US)$ Can be my PM gapper. Low float EV stock. IPO las...
$Damon Inc (DMN.US)$ Can be my PM gapper. Low float EV stock. IPO las...
35
19
5
$Monogram Orthopaedics (MGRM.US)$
Monogram Technologies Announces Management and Related Parties Complete Open Market Purchases of MGRM Common Stock Totaling $1 Million
Monday, 2nd December at 4:05 pm
AUSTIN, TEXAS / ACCESSWIRE / December 2, 2024 / Monogram Technologies Inc. (NASDAQ: MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, today announced completed purchases of MGRM common stock on the o...
Monogram Technologies Announces Management and Related Parties Complete Open Market Purchases of MGRM Common Stock Totaling $1 Million
Monday, 2nd December at 4:05 pm
AUSTIN, TEXAS / ACCESSWIRE / December 2, 2024 / Monogram Technologies Inc. (NASDAQ: MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, today announced completed purchases of MGRM common stock on the o...
$Monogram Orthopaedics (MGRM.US)$ Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
3 MINUTES AGO, 8:31 AM EDT
VIA ACCESSWIRE
3 MINUTES AGO, 8:31 AM EDT
VIA ACCESSWIRE
$Monogram Orthopaedics (MGRM.US)$
Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering
Monogram Technologies Inc. (NASDAQ:MGRM) has successfully closed its upsized and oversubscribed $13 million public offering of 8.00% Series D Convertible Cumulative Preferred Stock. The company sold 5,790,479 units, each comprising one share of Series D Preferred Stock and one common stock purchase warrant. The offering attracted 3,023 investors and provi...
Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering
Monogram Technologies Inc. (NASDAQ:MGRM) has successfully closed its upsized and oversubscribed $13 million public offering of 8.00% Series D Convertible Cumulative Preferred Stock. The company sold 5,790,479 units, each comprising one share of Series D Preferred Stock and one common stock purchase warrant. The offering attracted 3,023 investors and provi...
$Monogram Orthopaedics (MGRM.US)$
Monogram Technologies Receives FDA Response for mBôs TKA System
Monogram Technologies (NASDAQ:MGRM) has received an Additional Information Request (AIR) from the FDA regarding its 510(k) premarket filing for the mBôs TKA System. The company has 180 days to respond or the application will be considered withdrawn. Monogram plans to conduct clinical trials to produce the required information.
CEO Ben Sexson stated that this response provides more clarity on the ...
Monogram Technologies Receives FDA Response for mBôs TKA System
Monogram Technologies (NASDAQ:MGRM) has received an Additional Information Request (AIR) from the FDA regarding its 510(k) premarket filing for the mBôs TKA System. The company has 180 days to respond or the application will be considered withdrawn. Monogram plans to conduct clinical trials to produce the required information.
CEO Ben Sexson stated that this response provides more clarity on the ...
$Monogram Orthopaedics (MGRM.US)$
Monogram Technologies Reports Second Quarter 2024 Financial Results
Monogram Technologies (NASDAQ:MGRM) reported its Q2 2024 financial results, highlighting key operational achievements.
The company submitted a 510(k) premarket filing to the FDA for its mBôs TKA System, which passed the administrative review.
Monogram also secured a strategic collaboration with Shalby for multicenter clinical trials in India.
Financial results showed R&D expenses decrea...
Monogram Technologies Reports Second Quarter 2024 Financial Results
Monogram Technologies (NASDAQ:MGRM) reported its Q2 2024 financial results, highlighting key operational achievements.
The company submitted a 510(k) premarket filing to the FDA for its mBôs TKA System, which passed the administrative review.
Monogram also secured a strategic collaboration with Shalby for multicenter clinical trials in India.
Financial results showed R&D expenses decrea...
4
$Monogram Orthopaedics (MGRM.US)$
Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration
Monogram Technologies Inc. (NASDAQ:MGRM) has announced a strategic collaboration with Shalby (NSE:SHALBY) to conduct a multicenter clinical trial for its mBȏs TKA System. Shalby, the world's largest orthopedic hospital chain, will enroll patients at various sites in India to evaluate the system's safety and effectiveness. This collaboration follows Monogram's recent 510(k) submissio...
Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration
Monogram Technologies Inc. (NASDAQ:MGRM) has announced a strategic collaboration with Shalby (NSE:SHALBY) to conduct a multicenter clinical trial for its mBȏs TKA System. Shalby, the world's largest orthopedic hospital chain, will enroll patients at various sites in India to evaluate the system's safety and effectiveness. This collaboration follows Monogram's recent 510(k) submissio...
1
$Monogram Orthopaedics (MGRM.US)$
Monogram Technologies Submits 510(k) Application for MBôs TKA System Clearance
Application was Submitted on July 19, 2024, Passed the FDA Administrative Review, and is Now Under Substantive Review
FDA Decision is Expected Within 90 Days of Initial Submission; However, the Process May be Paused if Additional Information is Requested
Monogram Technologies Submits 510(k) Application for MBôs TKA System Clearance
Application was Submitted on July 19, 2024, Passed the FDA Administrative Review, and is Now Under Substantive Review
FDA Decision is Expected Within 90 Days of Initial Submission; However, the Process May be Paused if Additional Information is Requested
2
$Monogram Orthopaedics (MGRM.US)$ Monogram Orthopaedics Inc - Provides Regulatory Update Following Meeting With FDA! 510(K) submission with FDA accelerated for early 2H of 2024!
2
$Monogram Orthopaedics (MGRM.US)$Made a huge mistake by buying this trash stock.
1
2
No comment yet
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Mr Brooks : Thank you. You are amazing. !!!
Trytosaveabit : As you know I’ve been waiting for this 510 clearance! I know most don’t like it! And admittedly the chart and volume are not looking good! Hehehe! But I really like, have like and continue to like MOVE! Hehehe! People don’t realize just how superior this is over the junk you can just buy on Amazon! Hehehe
Jaguar8 OP Trytosaveabit : Yes it took forever for this EvieRing to get cleared even with superior results . Glad they had it
Trytosaveabit Jaguar8 OP : Yup yup! I knew at one point you felt as I do! Not sure where you stand these days? Hehehe.
Jaguar8 OP Trytosaveabit : It was just parked on my FDA watchlist and waited forever![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
View more comments...